These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10395875)

  • 1. Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection.
    Lefrère JJ; Mariotti M; Morand-Joubert L; Thauvin M; Roudot-Thoraval F
    J Infect Dis; 1999 Aug; 180(2):526-9. PubMed ID: 10395875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.
    de Mendoza C; Soriano V; Pérez-Olmeda M; Rodés B; Casas E; González-Lahoz J
    J Hum Virol; 1999; 2(6):344-9. PubMed ID: 10774551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda.
    Gray RH; Li X; Wawer MJ; Serwadda D; Sewankambo NK; Wabwire-Mangen F; Lutalo T; Kiwanuka N; Kigozi G; Nalugoda F; Meehan MP; Robb M; Quinn TC
    J Infect Dis; 2004 Apr; 189(7):1209-15. PubMed ID: 15031789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.
    Lyles RH; Muñoz A; Yamashita TE; Bazmi H; Detels R; Rinaldo CR; Margolick JB; Phair JP; Mellors JW
    J Infect Dis; 2000 Mar; 181(3):872-80. PubMed ID: 10720507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.
    Ioannidis JP; Abrams EJ; Ammann A; Bulterys M; Goedert JJ; Gray L; Korber BT; Mayaux MJ; Mofenson LM; Newell ML; Shapiro DE; Teglas JP; Wilfert CM
    J Infect Dis; 2001 Feb; 183(4):539-45. PubMed ID: 11170978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.
    Podsadecki TJ; Vrijens BC; Tousset EP; Rode RA; Hanna GJ
    J Infect Dis; 2007 Dec; 196(12):1773-8. PubMed ID: 18190257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic silica extraction for low-viremia human immunodeficiency virus type 1 genotyping.
    McClernon DR; Ramsey E; Clair MS
    J Clin Microbiol; 2007 Feb; 45(2):572-4. PubMed ID: 17122019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
    Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
    J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in human immunodeficiency virus type 1 (HIV-1) load among HIV-1-infected children with hemophilia.
    Engels EA; Rosenberg PS; Katki H; Goedert JJ; Biggar RJ;
    J Infect Dis; 2001 Aug; 184(3):364-8. PubMed ID: 11443565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
    Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H
    Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
    Blattner WA; Oursler KA; Cleghorn F; Charurat M; Sill A; Bartholomew C; Jack N; O'Brien T; Edwards J; Tomaras G; Weinhold K; Greenberg M
    J Infect Dis; 2004 May; 189(10):1793-801. PubMed ID: 15122515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Sungkanuparph S; Groger RK; Overton ET; Fraser VJ; Powderly WG
    HIV Med; 2006 Oct; 7(7):437-41. PubMed ID: 16925729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.